Antara Capsule
Pricing Report NDC 27437-110-06

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The latest wholesale acquisition cost for Antara (NDC 27437-110-06) is $6.21481 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 19, 2014.

As a a human prescription drug provided by Lupin Pharmaceuticals, Inc., this medication is distributed in a 30 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$6.21481
Per EA

Effective Date
Feb 19, 2014
Billable Units
30 EA
Estimated Package Price
$186.44
Data Status
As of Mar 11, 2015
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 CAPSULE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $4.68075 (Effective: Feb 18, 2015)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Mar 2013, the NADAC wholesale price for (NDC ) has moved within a range of $6.21481 to $6.23207 per EA. Over this 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$6.2148 - $6.2321
Market Volatility
0.28% Variance
Latest Trend
0.28%
Date Unit Price Unit Source Method Rate
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Feb 19, 2014 $6.21481 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Mar 21, 2013 $6.23207 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 21, 2013 $6.23207 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 21, 2013 $6.23207 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 21, 2013 $6.23207 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 21, 2013 $6.23207 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Mar 21, 2013 $6.23207 EAC/I - Chain or Independent PharmacyCode 2B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026